Contrasting Marpai (NASDAQ:MRAI) and NewGenIvf Group (NASDAQ:NIVF)

NewGenIvf Group (NASDAQ:NIVF) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Profitability

This table compares NewGenIvf Group and Marpai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Marpai	-92.76%	N/A	-99.32%

Insider & Institutional Ownership

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 61.3% of Marpai shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares NewGenIvf Group and Marpai”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$5.14 million	0.50	$130,000.00	N/A	N/A
Marpai	$34.87 million	0.15	-$28.75 million	($3.19)	-0.15

NewGenIvf Group has higher earnings, but lower revenue than Marpai.

Volatility & Risk

NewGenIvf Group has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500. Comparatively, Marpai has a beta of 4.85, meaning that its share price is 385% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for NewGenIvf Group and Marpai, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	0	0	0	0	N/A
Marpai	0	0	1	0	3.00

Marpai has a consensus price target of $6.00, indicating a potential upside of 1,147.40%. Given Marpai’s higher probable upside, analysts clearly believe Marpai is more favorable than NewGenIvf Group.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.

About Marpai

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.